Dr. Brian P. Cervenka, MD

Dr. Cervenka practices at UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth.

Dr. Cervenka's NPI, 1710327358, was assigned on June 27, 2013. Dr. Cervenka graduated from University of Southern California Keck School of Medicine in 2013. Dr. Cervenka holds Colorado license DR0067707.

Dr. Cervenka's primary practice is UCHealth University of Colorado Hospital, at 12605 E 16th Ave, Aurora, CO 80045 in Adams County. The practice phone is (720) 848-0000.

Dr. Cervenka's primary practice is UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth. Dr. Cervenka is also affiliated with Children's Hospital Colorado Anschutz Medical Campus. The medical group on file is University of Colorado Medicine (CU Medicine). Dmand AI also links Dr. Cervenka to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cervenka practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Cervenka's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Dr. Cervenka's licenses on file in 3 states: Colorado, Ohio and Tennessee.

CMS data shows 366 Medicare services from Dr. Cervenka across 9 procedure codes in 2024, for 182 Medicare patients. Medicare paid $43,946 for them.

CMS counts 182 Medicare patients who saw Dr. Cervenka in 2024. The largest group is 65 to 74, with 95 patients. 65% of them have high cholesterol, and 64% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cervenka's median patient age at 71, with 41% women.

In 2024, Dr. Cervenka wrote 67 Medicare Part D claims for 28 patients. 96% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $124 in total drug cost. In 2021, CMS named 12 claims across 1 drug.

Dr. Cervenka accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cervenka as offering telehealth. CMS counts 15 procedures of melanoma (skin cancer) excision by Dr. Cervenka, more than 70% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 21 papers to Dr. Cervenka, published from 2013 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Plastic Surgery Procedures, Free Tissue Flaps and Education, Medical, Graduate. Dr. Cervenka has published most often in Curr Opin Otolaryngol Head Neck Surg. Dr. Cervenka's most frequent co-authors are Chad A. Zender, MD, Arnaud F. Bewley, MD and Yash J. Patil, MD, MPH.

CMS Open Payments shows 18 general payments to Dr. Cervenka from 9 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 71% of the total. Inspire Medical Systems, Inc. paid the most, $814.

Dr. Cervenka graduated from University of Southern California Keck School of Medicine in 2013.